What Nvidia must deliver in earnings this week to remain AI king
It’s all about to happen. But until it happens, then no money should be made waiting for it. We have to see its success to invest in it. Otherwise, the …
Merck & Co Inc
Eli Lilly (LLY) says it can overcome high-quality problem of too much demand
Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly …
Merck (MRK) earnings Q1 2024
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings …
Earnings from Tesla, Merck and Big Tech
CNBC Investing Club with Jim Cramer Rob Kim | NBCUniversal CNBC’s Jim Cramer on Friday noted that major quarterly results from players like Verizon, Meta, Microsoft and Alphabet will be coming next …
FDA approves Merck drug sotatercept for rare, deadly lung condition
The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for …
First NASH liver disease drug is here, more coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign …
What’s next in Medicare drug price negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | …
Pfizer is betting big on cancer drugs after Covid decline
Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help it regain its footing after a …
Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues
Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The approval of two gene therapies to treat sickle cell disease has given hope …
Moderna (MRNA) earnings Q4 2023
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid …